10.3205/09DGNC286
Thon, N.
N.
Thon
Eigenbrod, S.
S.
Eigenbrod
Egensperger, R.
R.
Egensperger
Kretzschmar, H.
H.
Kretzschmar
Lutz, J.
J.
Lutz
Tonn, J.-C.
J.-C.
Tonn
Kreth, F.-W.
F.-W.
Kreth
Prognostic relevance of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from glioblastomas after primary concomitant radiochemo-therapy followed by adjuvant temozolomide
German Medical Science GMS Publishing House
2009
ConferencePaper
610 Medical sciences; Medicine
Deutsche Gesellschaft Für Neurochirurgie
2009-05-20
2009
en
urn:nbn:de:0183-09dgnc2861
09dgnc286
text/html
60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien
Objective: Epigenetic silencing of the MGMT gene has been linked to favorable prognosis in glioblastomas (GBM) after treatment according to the EORTC protocol even when stratified for the extent of surgery except for patients who undergo biopsy only. Aim of this study was to evaluate the prognostic [for full text, please go to the a.m. URL]
60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien